-
Company Profile
![]()
KYORIN Holdings Inc – Company Profile
KYORIN Pharmaceutical Co Ltd (Kyorin), formerly KYORIN Holdings Inc, manufactures, develops and commercializes pharmaceuticals including new ethical drugs, generic drugs and over-the-counter (OTC) drugs. The company offers diagnostics, reagents, intermediates, industrial chemicals and other products. Kyorin markets its products under Kipres, Mucodyne, Pentasa, Uritos, Ketas, Flutiform, Milton, Rubysta and other brands. It also provides solutions to medical professionals in infection-related fields. The company operates its business through its subsidiaries KYORIN Rimedio Co Ltd and KYORIN Pharmaceutical Group Facilities Co Ltd...
Add to Basket -
Product Insights
![]()
Net Present Value Model: Singulair
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Singulair Drug Details Montelukast sodium (Singulair...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.